DK33488A - D-gl-konjugatterapi - Google Patents

D-gl-konjugatterapi

Info

Publication number
DK33488A
DK33488A DK033488A DK33488A DK33488A DK 33488 A DK33488 A DK 33488A DK 033488 A DK033488 A DK 033488A DK 33488 A DK33488 A DK 33488A DK 33488 A DK33488 A DK 33488A
Authority
DK
Denmark
Prior art keywords
conjugath
therapy
lysine
antibody
polymers
Prior art date
Application number
DK033488A
Other languages
English (en)
Other versions
DK33488D0 (da
Inventor
David H Katz
Original Assignee
Quidel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quidel filed Critical Quidel
Publication of DK33488A publication Critical patent/DK33488A/da
Publication of DK33488D0 publication Critical patent/DK33488D0/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/645Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK033488A 1986-05-30 1988-01-25 D-gl-konjugatterapi DK33488D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86939386A 1986-05-30 1986-05-30
PCT/US1987/000197 WO1987007145A1 (en) 1986-05-30 1987-02-02 D-gl conjugate therapy

Publications (2)

Publication Number Publication Date
DK33488A true DK33488A (da) 1988-01-25
DK33488D0 DK33488D0 (da) 1988-01-25

Family

ID=25353468

Family Applications (1)

Application Number Title Priority Date Filing Date
DK033488A DK33488D0 (da) 1986-05-30 1988-01-25 D-gl-konjugatterapi

Country Status (8)

Country Link
EP (1) EP0272278B1 (da)
JP (1) JPS63503457A (da)
AT (1) ATE90876T1 (da)
CA (1) CA1309558C (da)
DE (1) DE3786334T2 (da)
DK (1) DK33488D0 (da)
NO (1) NO880376L (da)
WO (1) WO1987007145A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6441025B2 (en) * 1996-03-12 2002-08-27 Pg-Txl Company, L.P. Water soluble paclitaxel derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4191668A (en) * 1977-02-03 1980-03-04 Scripps Clinic And Research Foundation Induction of immunological tolerance

Also Published As

Publication number Publication date
CA1309558C (en) 1992-10-27
JPS63503457A (ja) 1988-12-15
NO880376D0 (no) 1988-01-28
ATE90876T1 (de) 1993-07-15
EP0272278B1 (en) 1993-06-23
AU7082987A (en) 1987-12-22
EP0272278A4 (en) 1990-01-08
DE3786334D1 (de) 1993-07-29
DE3786334T2 (de) 1993-12-02
NO880376L (no) 1988-01-28
WO1987007145A1 (en) 1987-12-03
EP0272278A1 (en) 1988-06-29
DK33488D0 (da) 1988-01-25
AU604687B2 (en) 1991-01-03

Similar Documents

Publication Publication Date Title
AU1049788A (en) Methods and peptides for the treatment of non-ige-mediated diseases
KR930702026A (ko) 자기항원의 경구 투여에 의한 자기면역 질병의 치료
DK651689A (da) Oralt autoantigenholdigt praeparat
PT627933E (pt) Supressao "bystander" de doencas autoimunes
NO971355L (no) Fotodynamiske terapi i selektiv celleinaktivering i blod og behandling av immundysfunksjons-sykdommer
PT920322E (pt) Tratamento de doencas autoimunes
CY1108318T1 (el) Διεγερση των κυτταρων τ εναντια στα δικα τους αντιγονα με τη χρηση των παραγοντων αποκλεισμου ctla-4
EA200100721A1 (ru) Производное габапентина для предупреждения и лечения висцеральной боли
ATE245030T1 (de) Antigen-besierende heteropolymere zur behandlung von autoimmunkrankheiten mittels diesen
DK235687D0 (da) Tilberedninger til syntese af prostaglandiner og hydroxyfedtsyrer i biologiske systemer og anvendelse deraf
DE3781652D1 (de) Zubereitung, geeignet fuer die behandlung von darmstoerungen.
BG99074A (bg) Рекомбинантни човешки нiv-неутрализиращи моноклонални антитела за профилактика и лечение на нiv инфекция
DK33488D0 (da) D-gl-konjugatterapi
DK402485A (da) Tumorterapeutiskum og fremgangsmaade til dets fremstilling
NO986218L (no) FremgangsmÕte til Õ bestemme nµrvµr av hjerneprotein S-100
ES2115582T3 (es) Preparacion y aplicaciones de interferon-gamma.
RU96119817A (ru) Способ лечения дисбактериозов кишечника
SU1077090A1 (ru) Способ получени вещества,специфически св зывающего раково-эмбриональный антиген опухолей толстого кишечника человека
RU97117537A (ru) Мазь "черная" для лечения арахнозов, дерматомикозов и заболеваний кожи
RU94032140A (ru) Способ лечения афазии
Burnyasheva et al. On the question of the treatment of urticaria
FR2641182B1 (fr) Appareil de traitement par influence sur les pavillons auriculaires d'un sujet humain ou animal, de champs electriques modules
DE3680140D1 (de) Behandlung von parasiterkrankungen.
Shust 10-year results of programmed treatment of Hodgkin's disease patients
Ivankova et al. Modification of gynaecological cancer mixed forms treatment

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment